PAR6 ACUTE GOUTY ARTHRITIS- THE COSTEFFECTIVENESS OF A NEW SELECTIVE COX-2 INHIBITOR (ETORICOXIB) IN THE UK
Nov 1, 2003, 00:00 AM
10.1016/S1098-3015(10)61851-7
https://www.valueinhealthjournal.com/article/S1098-3015(10)61851-7/fulltext
Section Title :
Section Order :
299
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)61851-7&doi=10.1016/S1098-3015(10)61851-7